Identifying the drivers of patients' reliance on short-acting β2-agonists in asthma
Open Access
- 3 August 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 58 (8), 1094-1101
- https://doi.org/10.1080/02770903.2020.1761382
Abstract
Background:One of the most commonly observed asthma treatment patterns is the underuse of inhaled corticosteroid (ICS) maintenance therapy when patients are not experiencing symptoms, and the predominant use of short-acting beta 2-agonists (SABAs) when patients are experiencing symptoms. This multinational study investigated the current beliefs and behaviors related to reliance on reliever inhalers among asthma patients, and the reasons why patients may not adhere to their recommended maintenance controller treatment. Methods:This was a qualitative research study, in which 80 patients with asthma who were receiving reliever therapy (i.e. SABAs) were interviewed, in-depth, for 60 min. The interview questions focused on the patients' experience of living with asthma and their inhaled treatment regimens. Results:The key insights identified in the interviews were (a) patients had a strong emotional attachment to SABA relievers driven by their efficacy and success in quickly alleviating asthma symptoms, with the reliever also becoming an emotional support; (b) patients typically did not understand that the frequent use of SABAs indicates poor asthma control; (c) patients had a misperception of ICS, which could lead to a delay in escalation and poor adherence; and (d) severe exacerbations improve adherence to ICS, but only temporarily in many cases. Conclusion:This study confirmed the poor level of control patients have over their asthma, and how this affects their lifestyle and daily activities. Our results also confirmed that the patients' perception of both the disease and treatment plays a key role in SABA reliance and ICS underuse.Keywords
Funding Information
- AstraZeneca, Cambridge, UK
This publication has 29 references indexed in Scilit:
- Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespiratory Medicine, 2013
- Insights, attitudes and perceptions about asthma and its treatment: Findings from a multinational survey of patients from 8 Asia‐Pacific countries and Hong KongRespirology, 2013
- Asthma management and control in the United States: Results of the 2009 Asthma Insight and Management surveyAllergy and Asthma Proceedings, 2012
- Factors influencing patient decisions about the use of asthma controller medicationAnnals of Allergy, Asthma & Immunology, 2007
- Patient adherence to medical treatment: a review of reviewsBMC Health Services Research, 2007
- Compliance, Adherence, and ConcordanceChest, 2006
- Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?Journal of Pediatric Psychology, 2006
- Patterns of quick-relief and long-term controller medication use in pediatric asthmaThe Journal of Pediatrics, 2005
- Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonideThorax, 2004
- Adherence with Twice-daily Dosing of Inhaled SteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998